Kinase profiling. Researcher analysing protein kinase inhibitors to determine their selectivity as part of research into drug targeting. This technique is known as 'kinase profiling'. In recent years protein kinases have become the most studied class of drug target. Ten protein kinase inhibitors have now been approved as anti-cancer drugs and many more are undergoing clinical trials (as of 2012). Photographed at the International Centre for Kinase Profiling, Medical Research Council Protein Phosphorylation Unit, University of Dundee, UK.
Model release available. Property release not required.